首页> 美国卫生研究院文献>Molecules >Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals
【2h】

Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals

机译:镓放射性药物双功能螯合剂设计的现代发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The positron-emitting radionuclide gallium-68 has become increasingly utilised in both preclinical and clinical settings with positron emission tomography (PET). The synthesis of radiochemically pure gallium-68 radiopharmaceuticals relies on careful consideration of the coordination chemistry. The short half-life of 68 min necessitates rapid quantitative radiolabelling (≤10 min). Desirable radiolabelling conditions include near-neutral pH, ambient temperatures, and low chelator concentrations to achieve the desired apparent molar activity. This review presents a broad overview of the requirements of an efficient bifunctional chelator in relation to the aqueous coordination chemistry of gallium. Developments in bifunctional chelator design and application are then presented and grouped according to eight categories of bifunctional chelator: the macrocyclic chelators DOTA and TACN; the acyclic HBED, pyridinecarboxylates, siderophores, tris(hydroxypyridinones), and DTPA; and the mesocyclic diazepines.
机译:正电子发射放射性核素镓 68 在临床前和临床环境中越来越多地用于正电子发射断层扫描 (PET)。放射化学纯镓 68 放射性药物的合成依赖于对配位化学的仔细考虑。68 分钟的短半衰期需要快速定量放射性标记 (≤10 分钟)。理想的放射性标记条件包括接近中性的 pH 值、环境温度和低螯合剂浓度,以达到所需的表观摩尔活性。本文广泛概述了与镓水配位化学相关的高效双功能螯合剂的要求。然后介绍了双功能螯合剂设计和应用的发展,并根据八类双功能螯合剂进行分组:大环螯合剂 DOTA 和 TACN;无环 HBED、吡啶羧酸盐、铁载体、三(羟基吡啶酮)和 DTPA;和中环二氮卓类药物。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号